MagicMed CEO Dr. Joseph Tucker: Artificial Intelligence in the Psychedelics Sector

- March 22nd, 2021

MagicMed CEO Dr. Joseph Tucker joined Proactive’s talk discussion on artificial intelligence in the psychedelics sector.

MagicMed CEO Dr. Joseph Tucker joined Proactive’s talk discussion on artificial intelligence in the psychedelics sector. In the interview, Tucker says, “We’re using brand new technologies that very few people really understand.” He further shares that, “we see a really powerful tool with all kinds of opportunities,” as he references the company’s PsyAI™ and Psybrary™.

MagicMed’s Psybrary™ is designed to become one of the leading providers of novel drug candidates for the biotechnology and pharmaceutical industries.

Watch the full interview below.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply